摘要
<正>自2017年7月以来,黄热病(Yellow fever,YF)在巴西持续流行,至2018年5月,不到一年间登记确诊病例1 266例,死亡病例415例。YF的临床表现轻重不一,轻者表现为自限性,重者则表现为致命性。约10%~15%的患者出现ALF,病死率约40%~50%~([1]),表现为凝血障碍致无法控制的出血、急性肾损伤和休克。迄今无特别有效的治疗手段,巴西圣保罗大学医学中心报道1例黄热病诱发ALF的患者接受肝移植治疗~([2])。
引文
[1] Johansson MA,Vasconcelos PF ,Staples JE.The whole iceberg:estimating the incidence of yellow fever virus infection from the number of severe cases.Trans R Soc Trop Med Hyg,2014.108:482-487.
[2] Song,ATW,Abdala E,de Martino RB,et al.Liver trans-plantation for fulminant hepatitis attributed to yellow fever.Hepatology,2019.69:1349-1352.
[3] De Brito T,Siqueira SA,Santos RT,et al.Human fatal yellow fever.Immunohistochemical detection of viral antigens in the liver,kidney and heart.Pathol Res Pract,1992.188:177-181.
[4] Dias LB Jr ,Alves VA,Kanamura C,et al.Fulminant hepatic failure in northern Brazil:morphological,immunohistochemical and pathogenic aspects of Labrea hepatitis and yellow fever.Trans R Soc Trop Med Hyg,2007.101:831-839.